Cargando…
5013719 Method of effecting immunosuppression: Terry L Bowlin assigned to Merrell Dow Pharmaceuticals Inc
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
Published by Elsevier Ltd.
1992
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7133967/ http://dx.doi.org/10.1016/0147-9571(92)90021-I |
| _version_ | 1783517735475478528 |
|---|---|
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7133967 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 1992 |
| publisher | Published by Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-71339672020-04-08 5013719 Method of effecting immunosuppression: Terry L Bowlin assigned to Merrell Dow Pharmaceuticals Inc Comp Immunol Microbiol Infect Dis New Patent Published by Elsevier Ltd. 1992-10 2002-11-14 /pmc/articles/PMC7133967/ http://dx.doi.org/10.1016/0147-9571(92)90021-I Text en Copyright © 1992 Published by Elsevier Ltd. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | New Patent 5013719 Method of effecting immunosuppression: Terry L Bowlin assigned to Merrell Dow Pharmaceuticals Inc |
| title | 5013719 Method of effecting immunosuppression: Terry L Bowlin assigned to Merrell Dow Pharmaceuticals Inc |
| title_full | 5013719 Method of effecting immunosuppression: Terry L Bowlin assigned to Merrell Dow Pharmaceuticals Inc |
| title_fullStr | 5013719 Method of effecting immunosuppression: Terry L Bowlin assigned to Merrell Dow Pharmaceuticals Inc |
| title_full_unstemmed | 5013719 Method of effecting immunosuppression: Terry L Bowlin assigned to Merrell Dow Pharmaceuticals Inc |
| title_short | 5013719 Method of effecting immunosuppression: Terry L Bowlin assigned to Merrell Dow Pharmaceuticals Inc |
| title_sort | 5013719 method of effecting immunosuppression: terry l bowlin assigned to merrell dow pharmaceuticals inc |
| topic | New Patent |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7133967/ http://dx.doi.org/10.1016/0147-9571(92)90021-I |